D-Erythro-dihydrosphingosine

CAS No. 764-22-7

D-Erythro-dihydrosphingosine( Octadecasphinganine | Dihydrosphingosine | C18-Dihydrosphingosine | D-erythro-Sphinganine )

Catalog No. M26558 CAS No. 764-22-7

D-Erythro-dihydrosphingosine inhibits arachidonic acid release and cPLA2α activity.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 89 Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    D-Erythro-dihydrosphingosine
  • Note
    Research use only, not for human use.
  • Brief Description
    D-Erythro-dihydrosphingosine inhibits arachidonic acid release and cPLA2α activity.
  • Description
    D-Erythro-dihydrosphingosine inhibits arachidonic acid release and cPLA2α activity.(In Vitro):In PC12 cells, D-Erythro-dihydrosphingosine inhibits mastoparan-stimulated arachidonic acid release. D-Erythro-dihydrosphingosine (100 μM) slightly inhibits [3H]Arachidonic acid release.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Octadecasphinganine | Dihydrosphingosine | C18-Dihydrosphingosine | D-erythro-Sphinganine
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    Phospholipase
  • Recptor
    Human Endogenous Metabolite
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    764-22-7
  • Formula Weight
    301.51
  • Molecular Formula
    C18H39NO2
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?Ethanol : 50 mg/mL (165.83 mM)
  • SMILES
    CCCCCCCCCCCCCCC[C@@H](O)[C@@H](N)CO
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.H.K.Gardner, et al. Identification and Quantitation of Hexadecanal and Octadecanal in Broiler Muscle Phospholipids. Poultry Science, 1972 May 1; 51(3):1056-1058.
molnova catalog
related products
  • IACS-13909

    IACS-13909, a specific and potent allosteric inhibitor of SHP2, that suppresses signaling through the MAPK pathway.

  • Rapanone

    Rapanone is a natural benzoquinone that is a potent and selective inhibitor of human synovial PLA2.

  • Desketoraloxifene

    Desketoraloxifene is a selective estrogen receptor modulator, inhibiting mammalian PLD (PLD1 and PLD2).